{"id":"https://openalex.org/W2005390354","doi":"https://doi.org/10.1097/dad.0b013e3181660665","title":"Hand-Foot Syndrome With Sclerodactyly-Like Changes in a Patient Treated With Capecitabine","display_name":"Hand-Foot Syndrome With Sclerodactyly-Like Changes in a Patient Treated With Capecitabine","alternate_titles":[],"publication_year":2008,"publication_date":"2008-04-01","ids":{"openalex":"https://openalex.org/W2005390354","doi":"https://doi.org/10.1097/dad.0b013e3181660665","mag":"2005390354","pmid":"https://pubmed.ncbi.nlm.nih.gov/18360124"},"language":"en","primary_location":{"id":"doi:10.1097/dad.0b013e3181660665","doi":"https://doi.org/10.1097/dad.0b013e3181660665","is_oa":false,"landing_page_url":"https://doi.org/10.1097/dad.0b013e3181660665","pdf_url":null,"source":{"id":"https://openalex.org/S86638576","display_name":"American Journal of Dermatopathology","issn_l":"0193-1091","issn":["0193-1091","1533-0311"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Dermatopathology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005390354"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075114662","display_name":"Felicidade Trindade","orcid":"https://orcid.org/0000-0002-2824-7203","observed_orcids":["https://orcid.org/0000-0002-2824-7203"]},"institutions":[{"id":"https://openalex.org/I4210143200","display_name":"Hospital Santo Ant\u00f3nio dos Capuchos","ror":"https://ror.org/04abkkn33","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210095157","https://openalex.org/I4210143200"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"Felicidade Trindade","raw_affiliation_strings":["Department of Dermatology, Hospital dos Capuchos, Lisbon, Portugal. felicidade.trindade@gmail.com","Department of Dermatology, Hospital dos Capuchos, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Hospital dos Capuchos, Lisbon, Portugal. felicidade.trindade@gmail.com","institution_ids":["https://openalex.org/I4210143200"]},{"raw_affiliation_string":"Department of Dermatology, Hospital dos Capuchos, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210143200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078481076","display_name":"Rosario Haro","orcid":"https://orcid.org/0000-0002-9645-8504","observed_orcids":["https://orcid.org/0000-0002-9645-8504"]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]},{"id":"https://openalex.org/I4405264755","display_name":"Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/02whsjy88","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210129357","https://openalex.org/I4405264755"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rosario Haro","raw_affiliation_strings":["Department of Dermatology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain","institution_ids":["https://openalex.org/I4210129357","https://openalex.org/I4405264755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110022060","display_name":"Maria Carmen Fari\u00f1a","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]},{"id":"https://openalex.org/I4405264755","display_name":"Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/02whsjy88","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210129357","https://openalex.org/I4405264755"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Carmen Fari\u00f1a","raw_affiliation_strings":["Department of Dermatology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain","institution_ids":["https://openalex.org/I4210129357","https://openalex.org/I4405264755"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016746558","display_name":"Lu\u00eds Requena","orcid":"https://orcid.org/0000-0002-1347-3507","observed_orcids":["https://orcid.org/0000-0002-1347-3507"]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]},{"id":"https://openalex.org/I4405264755","display_name":"Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/02whsjy88","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210129357","https://openalex.org/I4405264755"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luis Requena","raw_affiliation_strings":["Department of Dermatology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain","institution_ids":["https://openalex.org/I4210129357","https://openalex.org/I4405264755"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5075114662"],"corresponding_institution_ids":["https://openalex.org/I4210143200"],"apc_list":null,"apc_paid":null,"fwci":1.0329,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.74902479,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"30","issue":"2","first_page":"172","last_page":"173"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12433","display_name":"Skin Diseases and Diabetes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9150000214576721},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.9940000176429749},{"id":"https://openalex.org/keywords/sclerodactyly","display_name":"sclerodactyly","score":0.9150000214576721},{"id":"https://openalex.org/keywords/drug-induced-skin-reaction","display_name":"drug-induced skin reaction","score":0.8420000076293945},{"id":"https://openalex.org/keywords/colon-adenocarcinoma","display_name":"colon adenocarcinoma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/fluoropyrimidine","display_name":"fluoropyrimidine","score":0.8130000233650208},{"id":"https://openalex.org/keywords/5-fluorouracil-prodrug","display_name":"5-fluorouracil prodrug","score":0.8799999952316284},{"id":"https://openalex.org/keywords/chemotherapy-induced-skin-toxicity","display_name":"chemotherapy-induced skin toxicity","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.9842175841331482},{"id":"https://openalex.org/C2775917601","wikidata":"https://www.wikidata.org/wiki/Q1424050","display_name":"Sclerodactyly","level":4,"score":0.9355977773666382},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7542519569396973},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5972470641136169},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5037285685539246},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.45776796340942383},{"id":"https://openalex.org/C2779515644","wikidata":"https://www.wikidata.org/wiki/Q718675","display_name":"Drug eruption","level":3,"score":0.44495877623558044},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4363710582256317},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4149472415447235},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.34121134877204895},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32435327768325806},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.31323879957199097},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.22530406713485718},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18000289797782898},{"id":"https://openalex.org/C2775981168","wikidata":"https://www.wikidata.org/wiki/Q239027","display_name":"Calcinosis","level":3,"score":0.1623823642730713},{"id":"https://openalex.org/C2780309369","wikidata":"https://www.wikidata.org/wiki/Q933382","display_name":"Calcification","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001707","descriptor_name":"Biopsy, Needle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006229","descriptor_name":"Hand Dermatoses","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006229","descriptor_name":"Hand Dermatoses","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012594","descriptor_name":"Scleroderma, Localized","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D012594","descriptor_name":"Scleroderma, Localized","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012811","descriptor_name":"Sigmoid Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012811","descriptor_name":"Sigmoid Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013577","descriptor_name":"Syndrome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/dad.0b013e3181660665","doi":"https://doi.org/10.1097/dad.0b013e3181660665","is_oa":false,"landing_page_url":"https://doi.org/10.1097/dad.0b013e3181660665","pdf_url":null,"source":{"id":"https://openalex.org/S86638576","display_name":"American Journal of Dermatopathology","issn_l":"0193-1091","issn":["0193-1091","1533-0311"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Dermatopathology","raw_type":"journal-article"},{"id":"pmid:18360124","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18360124","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of dermatopathology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1939003096","https://openalex.org/W1979186680","https://openalex.org/W1991441286","https://openalex.org/W2025258318","https://openalex.org/W2050684119","https://openalex.org/W2054612357","https://openalex.org/W2064920797","https://openalex.org/W2077562461","https://openalex.org/W2087675944","https://openalex.org/W2092325910","https://openalex.org/W2103359811","https://openalex.org/W2105939965","https://openalex.org/W2154594654","https://openalex.org/W2404738722"],"related_works":["https://openalex.org/W2154594654","https://openalex.org/W2070158972","https://openalex.org/W4282960003","https://openalex.org/W1901485463","https://openalex.org/W3008336949","https://openalex.org/W2117141238","https://openalex.org/W2399916976","https://openalex.org/W2315586981","https://openalex.org/W3031896965","https://openalex.org/W2108321310"],"abstract_inverted_index":{"Capecitabine,":[0],"a":[1,15,65,68],"fluoropyrimidine":[2],"carbamate":[3],"with":[4,38,50,55,67,73,76],"antineoplastic":[5],"activity,":[6],"is":[7,20],"an":[8],"oral":[9],"agent":[10],"that":[11],"was":[12],"developed":[13],"as":[14],"prodrug":[16],"of":[17,25,41],"5-fluorouracil":[18],"and":[19,28,52],"used":[21],"in":[22],"the":[23,39],"treatment":[24],"metastatic":[26],"colorectal":[27],"breast":[29],"cancers.":[30],"Multiple":[31],"cutaneous":[32],"adverse":[33],"effects":[34],"had":[35],"been":[36,59],"described":[37,60],"use":[40],"this":[42],"drug,":[43],"but":[44],"to":[45],"our":[46],"knowledge,":[47],"specific":[48],"association":[49],"capecitabine":[51],"hand-foot":[53,74],"syndrome":[54],"sclerodactyly-like":[56,77],"changes":[57,78],"has":[58],"only":[61],"once.":[62],"We":[63],"report":[64],"patient":[66],"colon":[69],"adenocarcinoma":[70],"who":[71],"presented":[72],"syndrome,":[75],"induced":[79],"by":[80],"capecitabine.":[81]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005390354","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
